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Abstract
Microbiome research has grown exponentially over
the past several years, but studies have been difficult
to reproduce across investigations. Relevant variation
in measurements between laboratories, from a variety
of sources, has not been systematically assessed. This
is coupled with a growing concern in the scientific
community about the lack of reproducibility in
biomedical research. The Microbiome Quality Control
project (MBQC) was initiated to identify sources of
variation in microbiome studies, to quantify their
magnitudes, and to assess the design and utility of
different positive and negative control strategies.
Here we report on the first MBQC baseline study
project and workshop.
Challenges faced by the microbiome field
The efficient characterization of the microbial ecology of
different human body sites using high-throughput se-
quencing has the potential to revolutionize research in
chronic disease etiology. However, significant methodo-
logical challenges must be overcome to allow widespread
application of these exciting new technologies. Two
major initiatives, the Human Microbiome Project
(HMP) [1] and MetaHIT [2], were launched to generate
resources characterizing the microbiome in health and
disease and to investigate the genes of the human intes-
tinal microbiota, respectively. These initiatives included
hundreds of individuals, and even with the associated
methodology development, few subsequent epidemio-
logical studies have evaluated the role of the microbiome
in population health. The degree of standardization neces-
sary for translation to large-scale studies is still in its in-
fancy. It is crucial that experts from myriad specialist
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areas - clinicians, epidemiologists, microbiologists, ecolo-
gists, immunologists, statisticians, and bioinformaticians -
work together to develop best practices and to identify
sources of potential measurement variability through
rigorous studies.
Addressing the sources of variation in microbiota profil-
ing is critical for optimizing protocols and for understand-
ing how best to combine different studies in a single
pooled analysis. Unfortunately, variation at each step in
the pipeline is enormous, from physical specimen col-
lection and processing to computational quantification
of microbial communities. The research community
has not yet characterized which of these variations in
protocols, both experimental and computational, may
overwhelm biological effects of interest. Consequently,
appreciation of the sources of variation in techniques,
and of their relative magnitudes, must be assessed
systematically.
Multi-center studies that assess technical variation
among identical specimen replicates, across laboratories,
and among protocols at each step in the pipeline, would
greatly inform the field. Variation may arise from sample
collection and storage methods, DNA extraction, PCR (for
amplicon studies), DNA sequencing, bioinformatics, and
statistical analyses. Large epidemiological studies of the
human microbiome require the replication of findings
across multiple populations, and pooling of data from
many different cohorts, which, in practice, will include
samples collected and processed at different times. To ad-
vance this field, it is essential to provide a palette of appro-
priate standards for each step of the assay process.
The MBQC project
The Microbiome Quality Control project, or MBQC, is a
collaborative effort designed to comprehensively evaluate
methods for measuring the human microbiome. The
project was inspired by earlier work in transcriptomics,
for example, the Microarray Quality Control project
(MAQC) [3], and we hope to improve the state-of-the-
science in microbial community sample collection, DNA
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extraction, sequencing, bioinformatics, and analyses, while
promoting open sharing of standard operating procedures
and best practices throughout the field. For the baseline
phase of the MBQC, we focused on comprehensively
evaluating methods for amplicon profiling of the human
fecal microbiome, including the techniques and protocols
for handling microbiome samples and computational
pipelines for microbial data processing.
Standard reference materials
At the time we planned the MBQC baseline, no standard
reference materials for positive and negative controls in
microbiome analysis (such as a National Institute of
Standards and Technology (NIST) standard reference
material) were available. We included two positive con-
trol standards in the project. First, we created a bulk
quality control (QC) sample that could be used through-
out the MBQC-base and in future studies. The labora-
tory of Dr. Emma Allen-Vercoe at the University of
Guelph, Canada, created a large quantity of fecal derived
material grown in a chemostat bioreactor (referred to as
the ‘bench-top colon’ or ‘Robogut’ [4]) that supports the
growth of anaerobes and can create liters of homogenous
material. This gave us material of identical composition
exceeding that provided by even the most generous stool
donor. These chemostat samples allowed us to assess
whether DNA extraction, amplification, or sequencing
choices leads to differences in microbiome measurements
when using an identical, controlled source. Routine inclu-
sion of comparable standard samples in future studies will
allow a single laboratory to assess their own performance
over time.
This chemostat positive control alone, however, has
several important limitations. First, although a large
volume can be produced, no one batch is limitless, and
it cannot be identically reproduced when the supply is
exhausted. Second, the full breadth of microbes pos-
sible across the human population cannot be repre-
sented in a single stool samples, and therefore a single
sample will not allow the detection of taxon-specific
artifacts induced by specific protocol changes. Third,
we have no gold standard measurement of the exact list
of organisms present in this sample or their true rela-
tive abundances.
To address this final limitation, we created an add-
itional positive control samples that we refer to as ‘artifi-
cial colonies’ or mock communities: one comprised of
20 species known to inhabit human stool and a second
comprised of 22 species from the human oral cavity. All
species were selected from HMP reference strains that
were originally isolated from humans. Each strain was
grown as a single culture and then mixed using a micro-
biological loop at fixed ratios (most at a 1:1 ratio, but
some at lower relative abundance). These specimens
provide ground truths and allow us to assess the validity
of a measurement method. To verify that our samples
contained only the 20 or 22 intended species, we com-
pleted shotgun sequencing of these samples. The artifi-
cial colonies also allow us to analyze the 16S rRNA
amplicon sequencing results directly by providing the
exact 16S rRNA gene sequences present in the samples.
MBQC study design
We used four types of samples in the MBQC: (1) 11
unique fresh stool samples; (2) seven unique freeze-dried
stool samples; (3) two unique chemostat samples generated
from a Robogut; and (4) two artificial colonies representing
the gut and oral cavity. DNA from these four types of sam-
ples was extracted at one central laboratory. Duplicates
and triplicates of both original and pre-extracted samples
were combined to produce a 96-element sample set. This
final set included 41 aliquots of centrally extracted DNA,
53 aliquots of the raw samples (frozen and freeze dried
feces, chemostat, and artificial colony), and two negative
control aliquots of storage buffer (10 mM Tris–HCl,
pH 8.5). Participating labs were blinded to the identities of
the samples.
Groups participating in the MBQC took part in either
or both of handling samples for data generation and/or
bioinformatics processing of the resulting data. Hand-
ling laboratories committed to extracting DNA from
raw samples, amplifying 16S rRNA gene fragments and
sequencing using either the Illumina MiSeq or HiSeq
platform, and providing the resulting data to the wider
group. To participate in the bioinformatics module, la-
boratories were asked to take re-blinded, demultiplexed
Illumina FASTQ files and provide one Operational
Taxonomic Unit (OTU) table and one phylogenetic tree
as the final output (although labs were able to provide
multiple final outputs, including, for example, closed-
reference OTU tables defined by database match or open-
reference or de novo OTU tables identifying new taxa).
Sixteen laboratories participated in the handling aspect
and nine laboratories participated in the bioinformatics
module of the MBQC.
Each of the handling laboratories independently chose
protocols for DNA extraction, PCR amplification, and
sequencing, which were then recorded in standardized
templates at a high level of detail. This resulted in data
from seven different DNA extraction kits and two differ-
ent 16S hypervariable region primers (V4 515 F/806R [5,
6] and V3-4 318 F/806R [7]), and while the majority of
labs (12 of 16) reported using homogenization during
DNA extraction, not all labs included this step. All labora-
tories save one generated data using the Illumina MiSeq
platform, and the final laboratory used a HiSeq 2500, most
(14 of 16) in paired end mode. The resulting read lengths
varied between 150 to 300 nucleotides, with PhiX control
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percentages spanning a wide range from none to 30 %. Ul-
timately, raw data comprised some 155 million total reads
from 2,238 samples, including replicate sequencing from
some groups, and a span from 57 % (on HiSeq) to 96 %
quality bases per sample.
Bioinformatics participants also each used their own
protocols of choice, which were again subsequently re-
corded. Typical bioinformatic steps included removal of
low-quality bases or shortened reads (for example, by
Trimmomatic [8]), paired read stitching (for example,
by PANDAseq [9]), OTU construction (for example, by
QIIME [10] or UPARSE [11]), and quality control of
the resulting table. A total of 16,555 samples were ana-
lyzed after incorporating replicates from all nine labs, and
the final OTU tables were assessed to identify the effects
of wet- and dry-lab protocol variables on within-sample
(for example, alpha-diversity and clade abundances) and
between-sample (for example, beta-diversity) analyses.
Preliminary results
The scope of the MBQC baseline is of necessity pre-
liminary, given the limited funding available with
which to survey only a few sample types, data gener-
ation strategies, and computational pipelines, primarily
by much-appreciated volunteer effort. However, two
encouraging initial conclusions can be drawn from the
project’s surprisingly extensive data, which comprised
over 155 million sequence reads and some 16,555 fully
analyzed samples, more than the Human Microbiome
Project itself. First, a relatively small number of labora-
tory protocol and bioinformatics variables accounted
for the majority of detected variability; many potential
sources of variation, such as sequencing platform or
error rate, proved to have at most very small effects.
Second, these sources of technical variability were gen-
erally of the same order of magnitude as those induced
by biological phenotypes, suggesting that they can be
overcome in most studies by careful adherence to stan-
dardized protocols. However, the complex patterns of
differences between analyzed samples ultimately sug-
gested complex interactions between sample, extrac-
tion, and bioinformatics in terms of arriving at an
overall profile of the microbes in a given sample.
Experimentally, DNA extraction method was a major
source of variation, although in the baseline study design
this was largely confounded with the lab performing the
analysis. This represents one of several additional study
design elements to be incorporated into a full-scale
MBQC, with each DNA extraction kit tested in multiple
labs. The choice of 16S amplification primer produced
as large or larger an effect on generated data, although
again only a few such primers were evaluated during the
baseline, and sequencing depth and sample storage and
transportation both had relatively small but detectable
effects on microbiome data generation.
Positive and negative controls, in the form of mock
communities (of known composition) and samples con-
taining no DNA, were particularly informative for qual-
ity control. Approximately half of sample handling labs
produced a non-trivial number of reads for negative
control samples, although this was likely due mainly to
differences in sample exclusion between labs (due to
low DNA concentration). Some bioinformatics proto-
cols were able to reduce the number of false positive
OTUs in these samples, but in most cases when a nega-
tive control sample was sequenced, it resulted in up to
several hundred putative OTUs. Positive controls like-
wise were often analyzed as containing between 50 and
150 OTUs, instead of the target 20. These spurious
OTUs were typically in the correct phylogenetic areas,
as indicated by low UniFrac distances to the known
true composition, with the main variation in accuracy
in this case again arising from wet- rather than dry-lab
protocol choices. Intriguingly, many of these spurious
OTUs may be due to bleed-through from other samples
sequenced simultaneously, since they were generally
derived from gut-resident microbes seen at much
higher abundance in the fecal samples in adjacent wells.
Different bioinformatics pipelines varied greatly in
putative OTU table composition and in their absolute
alpha- and beta-diversity estimates, but similar patterns
appeared across samples with almost all pipelines.
Quality control choices were among the largest sources
of variability among bioinformatics protocols, both at
the level of raw sequences (for example, quality trim-
ming, filtering, and stitching) and at the level of feature
(that is, OTU) or sample removal from the final table.
Different choices of OTU construction strategies, ranging
from unsupervised clustering to direct classification, also
induced smaller differences in inferred taxonomic com-
position. Ultimately, reproducibility underlies the replica-
tion of results needed to draw inferences regarding health
and disease for epidemiologic studies, making appropriate
standardized bioinformatics protocols as or more crucial
than experimental procedures for consistency over time
and laboratory, especially for longitudinal studies.
All data from the MBQC baseline study are available
from the SRA under BioProject ID SRP047083.
MBQC baseline conclusions
There was a consensus across the MBQC participating
groups that although microbiome measurements face
substantial challenges, this baseline project was very suc-
cessful and represented impressive progress towards the
overall goal of establishing practical guidelines for repro-
ducibility within labs over time and across the field. The
benefits to maximizing reproducibility are clear: overall
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increase in scientific rigor, reduction of redundant effort
from researchers developing their own methods, improv-
ing the meaningfulness of comparing results from inde-
pendent studies, and increasing power and sample size
by meta-analytic combinations of results from multiple
studies.
Aims of the consortium for the future
For the future, it would be useful to expand the MBQC
project in several directions. These include: (1) more di-
verse sample sources and collection methods; (2) develop-
ing further standard reference and control materials; (3)
expanding the MBQC baseline study to include swapping
samples between laboratories, replication of protocols
among laboratories, and focusing on the details of proto-
col variables highlighted by the baseline (for example,
extraction and PCR); (4) defining the contaminant profiles
of common reagents; (5) comprehensively evaluating vari-
ables using a Latin square or comparable spike-in design;
and (6) open access teaching materials and workshops
that would share these results allowing labs to define best
practices in human microbiome studies.
1. Sample collection
It is important to evaluate and standardize sample
collection protocols to reliably measure the human
microbiome in large-scale population studies. Best
practices for collections of microbiome samples
from different anatomic sites (for example, gut, cervix,
oral cavity, and skin) must be considered in the con-
text of overall study designs. For example, particularly
stringent collection protocols for clinic-based studies
are not feasible for large epidemiologic research in
which acceptability by participant is paramount
and controlling cost is essential. To expand human
microbiome research into the population sciences for
etiologic research, several issues are pertinent. First,
the method of collection must preserve the
microbial signature for each sample. Second, collection
and storage conditions must render the biological
sample stable under field conditions over an extended
period of time in less than optimal storage conditions.
Third, samples collected in a prospective study
should be preserved in a way that maximizes its
potential for use with multiple platforms (for example,
microbiomics, metabolomics, transcriptomics).
Finally, future epidemiologic studies of the micro-
biome will likely need to be very large to adjust for
multiple comparisons and data may need to be
pooled or meta-analyzed from multiple studies
from different laboratories.
Further questions will need to be considered in
evaluating sample collection for diverse populations,
body sites, study purposes, and epidemiological
contexts. It is important to reflect on whether a
portion of the sample represents the ‘whole’ of the
site-specific microbiome of an individual or whether
there is need to collect multiple aliquots from the same
sample (for example, the degree to which within-
sample biogeography matters for a stool sample). In
some contexts, a one-time collection may be adequate,
while in others multiple collections from individuals
over time may be necessary. Different sampling
devices and collection media are available and need to
be evaluated side-by-side for both ease of use and
integrity of sample. Storage at −80 °C is a standard
protocol, but the impact of long-term archival
storage and freezing and thawing of samples on the
integrity of microbiome is still an open question.
In summary, more work is required to develop
standardized sample collection protocol for field
studies that will allow reproducible and valid
characterization of the microbiome.
2. Ideal standard reference materials
Positive and negative controls are vital for any
experiment, and their adoption through standard
reference materials in the context of human
microbiome studies is still in flux. The MBQC used
two types of standards, produced in a chemostat and
artificial colonies, but neither constitutes a sufficient
standard reference material for all microbiome
research. Ideally, positive control reference materials
would include curated taxa representing many body
habitats, or be site- or population-specific to mimic
a ‘typical’ microbial community for broad classes
of studies. Considerations for such controls include
taxa with a variety of GC contents, mixed in widely
staggered ratios, and with absolute quantitation
of the number of cells and/or genomes included.
Negative control requirements are equally critical,
including blanks for each kit or preparation reagent
used during sample handling, and in some cases
within- and between-batch spatial or temporal
replication as well. Both types of controls will
improve our ability to normalize across batches
and between experiments. Producing such types
of standards requires the concerted efforts of the
community and of experienced organizations such as
the National Institute of Standards and Technology.
3. Expand the MBQC baseline study
Although the MBQC baseline has yielded
scientifically interesting and technically significant
results, far more remains to be done to scale
human microbiome research over the next years
and decades. Only 16S rRNA amplicon analyses
were performed during the baseline study, leaving
extension of the results to other ‘omics techniques
as an especially valuable next step, as similar
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questions apply to metagenomics,
metatranscriptomics, metaproteomics, and
metabolomics. This iteration did not examine
variability due to specimen collection or storage
protocols, yet we know that both of these can
have effect sizes that outweigh some of the more
subtle biological effects in real samples and patients.
While individual samples were replicated,
per-subject biological replicates, longitudinal
samples, and plate replicates were all insufficient
to allow analysis of variability among these other
replicate types. Similarly, the number of samples
from a given biological condition was, in general,
too low for detailed interpretation of which types
of variation among humans could be detected
against a background of methodological variation.
Consequently, an expanded MBQC that addresses
these important parameters could be of tremendous
value to the field.
Additionally, although we observed substantial
variation due to DNA extraction and sequencing
protocols, the features of non-standard protocols
were largely unique to individual laboratories,
making it impossible to isolate specific effects of
individual steps. This was of course not by design,
but due to the need to impose minimal proscriptive
restrictions on groups participating solely on a
volunteer basis and it helped us enumerate how
different labs implement their analyses. A future
study that runs the same set of varied protocols in
each of a number of labs would provide considerable
additional insight into which steps are critical to
reproducible results and which steps can be varied
without consequence, allowing the most attention to
be paid to the most important steps in the pipeline.
Swapping unextracted samples among laboratories
as well as swapping DNA among laboratories would
also help characterize these potential issues.
4. Define more reliable reagents
As microbiome studies move to lower input microbial
biomass, identifying and eliminating contaminants
in reagents that lead to incorrect detection of non-
biologically relevant taxa is increasingly important.
The blank wells throughout MBQC often yielded some
sequences, allowing insight into these contaminants,
although the scope of the baseline project did not
allow for testing reagent decontamination protocols.
The baseline also included only simple buffer blank
controls, whereas while carrying out diverse
experimental protocols, each kit or reagent can
introduce unique contaminants, sometimes varying
in their abundances by orders of magnitude and
able to swamp true biological signal from low-
biomass samples. A more detailed analysis of reagent
contamination and countermeasures to reduce it
could therefore be of substantial value to the field.
5. A comprehensive Latin square spike-in design
The results from the MBQC synthetic communities
highlight the need for additional studies of the
effects of DNA extraction and PCR on the ability
to accurately and precisely detect organisms at
different levels of abundance. This task is difficult
because detection limits may depend on specific
sequences as well as the underlying organismal
concentration, let alone different bioinformatics
strategies. One method of addressing this issue is
to use a Latin square (or comparable) design, in
which each protocol variable is modified at least
once in the hands of each different lab. This is
easiest in a setting where synthetic communities
are spiked into a background of replicate samples,
allowing readout of the known members of the
community in the context of a complex background.
Challenges to this design include the need to
standardize protocols across many labs, which was
impossible in the limited resource setting of the
baseline study. Additionally, it can be difficult to
construct synthetic communities of measurably
well-defined composition because of issues including
variation in copy number of the 16S rRNA gene,
DNA to biomass ratio, and so on. However, expanded
sets of spike-in controls of known composition would
substantially aid in quantifying accuracy, in addition
to variability, induced by each protocol variable
choice across labs. The Latin squares design can be
extended when feasible to any protocol variables in the
scope of the MBQC, experimental or computational,
allowing both the accuracy of taxonomic assessment
and variability from other protocol choices to be
evaluated systematically.
6. Teaching materials and workshops
Finally, there is tremendous demand in academia,
government, industry, and healthcare for workers
trained in robust microbiome analyses. This need of
course extends well beyond the scope of the MBQC
alone, but teaching materials based on the MBQC
experience, especially those aimed at describing
robust and reproducible analyses and at identifying
common pitfalls that can lead to incorrect results,
should be developed. Coupled with community
outreach and the incorporation of diverse researcher
feedback into future iterations of the project, we
anticipate that the standardization, open access data
generation, protocol sharing, and facilitation activities
of future expansions of the MBQC will be
instrumental in translating human microbiome
studies into an effective understanding of population-
level microbial community biology and public health.
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